Donald A. Wiebe
- Biochemistry top 1%
- Virology top 2%
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 9
- Emergency Medicine top 1%
-
- Vitamin D Research Studies 8
-
- Cancer, Lipids, and Metabolism 10
-
- Renal Transplantation Outcomes and Treatments 8
-
- Lipoproteins and Cardiovascular Health 7
-
- Pharmacological Effects and Toxicity Studies 7
-
- Analytical Chemistry and Chromatography 6
-
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Gary L. LensmeyerJames H. SteinNeil BinkleyJohn D. FoltsJon G. KeevilSusan E. AeschlimannJan FeyziRichard R. Love
- Partner nations
- United StatesUnited KingdomEgypt
In The Last Decade
Donald A. Wiebe
66 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 128
- Biochemistry 428
- Virology 338
- Endocrinology, Diabetes and Metabolism 752
- Emergency Medicine 427
- Pathology and Forensic Medicine 668
Countries citing papers authored by Donald A. Wiebe
This map shows the geographic impact of Donald A. Wiebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald A. Wiebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald A. Wiebe more than expected).
Fields of papers citing papers by Donald A. Wiebe
This network shows the impact of papers produced by Donald A. Wiebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald A. Wiebe. The network helps show where Donald A. Wiebe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Donald A. Wiebe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 7 | |
| 2 | 2013 | 27 | |
| 3 | 2011 | 144 | |
| 4 | 2010 | 67 | |
| 5 | 2007 | 47 | |
| 6 | 2004 | 31 | |
| 7 | 2001 | 101 | |
| 8 | 1998 | 194 | |
| 9 | 1997 | 59 | |
| 10 | 1994 | 226 | |
| 11 | 1991 | 11 | |
| 12 | 1991 | 46 | |
| 13 | 1991 | 3 | |
| 14 | Three commercial polyclonal immunoassays for cyclosporine in whole blood compared: 2. Cross-reactivity of the antisera with cyclosporine metabolites. | 1990 | 12 |
| 15 | 1990 | 3 | |
| 16 | 1990 | 9 | |
| 17 | 1988 | 11 | |
| 18 | 1987 | 34 | |
| 19 | 1986 | 35 | |
| 20 | 1979 | 9 |
About Donald A. Wiebe
Donald A. Wiebe is a scholar working on Transplantation, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 67 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Renal Transplantation Outcomes and Treatments (8 papers), Vitamin D Research Studies (8 papers), Lipoproteins and Cardiovascular Health (7 papers), Pharmacological Effects and Toxicity Studies (7 papers), Analytical Chemistry and Chromatography (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Biochemistry (428 citations), Virology (338 citations) and Endocrinology, Diabetes and Metabolism (752 citations). Donald A. Wiebe has collaborated with scholars based in United States, United Kingdom and Egypt. Frequent co-authors include Gary L. Lensmeyer, James H. Stein, Neil Binkley, John D. Folts, Jon G. Keevil, Susan E. Aeschlimann, Jan Feyzi, Richard R. Love, Polly A. Newcomb and Patrick E. McBride. Their work appears in journals such as Clinical Chemistry, Therapeutic Drug Monitoring, Circulation, JNCI Journal of the National Cancer Institute and Journal of Chromatographic Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.